Dr. Michael B Guillory , MD
Ophthalmology • Longview, TX
3209 N 4th St, Suite 100
Longview, TX 756055145
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Michael Guillory is listed in NPPES under Ophthalmology.
-
NPI assigned on July 6, 2006; this date does not establish years in practice.
-
Published CMS data list 513 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 92014 — Established patient complete exam of visual system: 236 service units.
- 92012 — Established patient problem focused exam of visual system: 83 service units.
- 92004 — New patient complete exam of visual system: 46 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 8 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 408 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Latanoprost — 191 prescription fills, including refills.
- Timolol Maleate — 50 prescription fills, including refills.
- Lumigan (Bimatoprost) — 32 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 11 records in the table · Guide: How to read Medicare Part D prescriber data
-
Fewer Medicare Part B services than 80% of clinicians listed under Ophthalmology in Texas (2024, 992 clinicians with data). Median for this group: 1,764. Middle half: 751 to 3,589.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 1,474 in 2020 to 513 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
3209 N 4th St
Suite 100
Longview, TX 756055145
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
Ophthalmology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
367 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $55,573 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $33,180 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
979 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$32,904 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Industry payments (Open Payments)
Fewer than 11 payment records totaling $17.94 in 2025
Drug and medical device companies must report certain payments to doctors and some other clinicians to CMS, such as meals, travel, speaking fees or research funding.
It shows reported financial ties between this clinician and companies. You can ask your clinician about them.
These records are submitted by drug and medical device companies, and a reported payment does not necessarily mean the financial relationship is improper.
General: payments not tied to research, such as meals, travel, consulting or speaking fees.
A reported payment does not necessarily mean the financial relationship is improper. Research payments can go to a hospital or university for a study the clinician leads, not to the clinician personally. Clinicians can dispute records with the company that reported them.
Source: CMS Open Payments, program year 2025.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Can order Medicare-covered services
CMS lists Dr. Guillory as eligible to order or refer durable medical equipment (DME) for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Longview and Texas
Billing and prescribing volume is not a quality rating.
Medicare Part B services
Fewer Medicare Part B services than 80% of clinicians listed under Ophthalmology in Texas (2024, 992 clinicians with data). Median for this group: 1,764. Middle half: 751 to 3,589.
Too few clinicians listed under Ophthalmology in Longview have Medicare Part B data for 2024 to compare.
Medicare-allowed amount
A lower Medicare-allowed amount than 80% of clinicians listed under Ophthalmology in Texas (2024, 992 clinicians with data). Median for this group: $211,752. Middle half: $85,606 to $415,016.
Too few clinicians listed under Ophthalmology in Longview have Medicare Part B data for 2024 to compare.
Paid by Medicare
A lower Medicare payment amount than 80% of clinicians listed under Ophthalmology in Texas (2024, 992 clinicians with data). Median for this group: $151,943. Middle half: $60,170 to $302,740.
Too few clinicians listed under Ophthalmology in Longview have Medicare Part B data for 2024 to compare.
Medicare Part D prescriptions
Fewer Part D prescriptions than 70% of clinicians listed under Ophthalmology in Texas (2024, 1,065 clinicians with data). Median for this group: 905. Middle half: 327 to 2,157.
Too few clinicians listed under Ophthalmology in Longview have Medicare Part D data for 2024 to compare.
Part D drug cost
A lower Part D drug cost than 60% of clinicians listed under Ophthalmology in Texas (2024, 1,065 clinicians with data). Median for this group: $73,797. Middle half: $14,089 to $240,265.
Too few clinicians listed under Ophthalmology in Longview have Medicare Part D data for 2024 to compare.
7 active clinicians are listed under Ophthalmology with a practice address in Longview, TX (1,517 in Texas).
Addresses are self-reported to NPPES and may be out of date.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services decreased 65% from 1,474 in 2020 to 513 in 2024.
- 2020: 1,474
- 2021: 1,346
- 2022: 1,250
- 2023: 1,183
- 2024: 513
-
Medicare-allowed amount
Medicare-allowed amount decreased 63% from $151,403 in 2020 to $55,573 in 2024.
- 2020: $151,403
- 2021: $146,146
- 2022: $134,119
- 2023: $118,713
- 2024: $55,573
-
Paid by Medicare
Paid by Medicare decreased 66% from $97,049 in 2020 to $33,180 in 2024.
- 2020: $97,049
- 2021: $96,304
- 2022: $87,637
- 2023: $80,601
- 2024: $33,180
-
Medicare Part D prescriptions
Medicare Part D prescriptions decreased 51% from 826 in 2020 to 408 in 2024.
- 2020: 826
- 2021: 729
- 2022: 698
- 2023: 643
- 2024: 408
-
30-day fills
30-day fills decreased 47% from 1,860 in 2020 to 979 in 2024.
- 2020: 1,860
- 2021: 1,645
- 2022: 1,615
- 2023: 1,495
- 2024: 979
-
Part D drug cost
Part D drug cost decreased 71% from $113,379 in 2020 to $32,904 in 2024.
- 2020: $113,379
- 2021: $101,463
- 2022: $102,930
- 2023: $75,995
- 2024: $32,904
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $29.20 in 2021 to $17.94 in 2025.
- 2021: $29.20
- 2025: $17.94
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): fewer than 11 records totaling $17.94.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
NUCALA | General | $17.94 |
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
92014
Established patient complete exam of visual system
|
236 | 235 | $123.00 | $122.70 |
|
92012
Established patient problem focused exam of visual system
|
83 | 78 | $86.62 | $86.87 |
|
92004
New patient complete exam of visual system
|
46 | 46 | $147.26 | $145.72 |
|
92133
Imaging of optic nerve
|
38 | 38 | $35.46 | $35.52 |
|
99212
Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
|
35 | 28 | $54.80 | $56.05 |
|
92083
Exam of visual field with extended testing
|
29 | 29 | $60.64 | $62.03 |
|
92134
Imaging of retina
|
26 | 26 | $39.13 | $39.34 |
|
66821
Removal of recurring cataract in lens capsule using a laser
|
20 | 16 | $321.46 | $328.47 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Latanoprost | Latanoprost | 191 | 14,960 | $2,552.84 | 80 |
| Timolol Maleate | Timolol Maleate | 50 | 3,733 | $431.58 | 23 |
| Lumigan | Bimatoprost | 32 | 1,657 | $14,271.01 | — |
| Dorzolamide Hcl | Dorzolamide Hcl | 23 | 1,625 | $441.33 | — |
| Prednisolone Acetate | Prednisolone Acetate | 22 | 1,460 | $1,000.90 | 11 |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 20 | 1,465 | $431.77 | — |
| Combigan | Brimonidine Tartrate/Timolol | 16 | 583 | $3,692.39 | — |
| Simbrinza | Brinzolamide/Brimonidine Tart | 16 | 910 | $6,379.91 | — |
| Brimonidine Tartrate | Brimonidine Tartrate | 15 | 1,069 | $179.85 | — |
| Fluorometholone | Fluorometholone | 12 | 1,078 | $1,296.60 | — |
| Brimonidine Tartrate-Timolol | Brimonidine Tartrate/Timolol | 11 | 560 | $2,225.91 | — |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 207W00000X
An ophthalmologist has the knowledge and professional skills needed to provide comprehensive eye and vision care. Ophthalmologists are medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, an ophthalmologist prescribes vision services, including glasses and contact lenses.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSSources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Ophthalmology
Doctor of Medicine (M.D.)
Career & Practice History
NPI enumerated July 06, 2006.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to August 2026.
NPI Administrative Meta
Other Ophthalmology Specialists in Longview
- Dr. Joel Muirhead, MD
- Dr. Craig King, MD
- Dr. David Risner, MD
- Dr. Jonathan Walgama, MD
- Dr. Sawyer Hall, DO
Mailing Address
3209 N 4th St, Suite 100
Longview, TX 756055145
Phone: 9037574662